|
|
|
Corporate Profile: Keryx Biopharmaceuticals
| Summary: |
Keryx Biopharmaceuticals is focused on the acquisition, development, and commercialization of products for the treatment of patients with cancer and renal disease.
|
| Address (HQ): |
750 Lexington Avenue
20th Floor
New York, NY 10022 |
| Phone #'s (HQ): |
| Main |
(212) 531-5965 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Fax #'s (HQ): |
| Main |
(212) 531-5961 |
| Human
Resources |
not known |
| Investor
Relations |
not known |
| Financial
information: |
| KERX |
| Issued United States patents: |
| Issued U.S. patents: 1976-present: patent
link. |
| Filed United States patent applications: |
| Filed U.S. patent applications: 2001-present: patent
link. |
| Publications on PubMed: |
| Scientific publications on PubMed with an author from the company: publications
link. |
|
|
|
